These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15164320)

  • 1. Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction.
    Shimabukuro M; Higa N; Asahi T; Oshiro Y; Takasu N
    Metabolism; 2004 Jun; 53(6):733-9. PubMed ID: 15164320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia.
    Sanada M; Higashi Y; Nakagawa K; Kodama I; Tsuda M; Nagai N; Chayama K; Ohama K
    Maturitas; 2003 Apr; 44(4):307-15. PubMed ID: 12697372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients.
    Inoue T; Hayashi M; Takayanagi K; Morooka S
    Atherosclerosis; 2002 Feb; 160(2):369-76. PubMed ID: 11849660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women.
    Higashi Y; Sanada M; Sasaki S; Nakagawa K; Goto C; Matsuura H; Ohama K; Chayama K; Oshima T
    Hypertension; 2001 Feb; 37(2 Pt 2):651-7. PubMed ID: 11230351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia.
    Inoue T; Takayanagi K; Hayashi T; Morooka S
    Int J Cardiol; 2003 Aug; 90(2-3):181-8. PubMed ID: 12957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory capacity of forearm resistance vessels is augmented in hypercholesterolemic patients after treatment with fluvastatin.
    Schobel HP; Schmieder RE
    Angiology; 1998 Sep; 49(9):743-8. PubMed ID: 9756426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.
    Schneider MP; Schmidt BM; John S; Schmieder RE
    J Hypertens; 2011 Sep; 29(9):1757-64. PubMed ID: 21799442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.
    März W; Scharnagl H; Abletshauser C; Hoffmann MM; Berg A; Keul J; Wieland H; Baumstark MW
    Circulation; 2001 Apr; 103(15):1942-8. PubMed ID: 11306521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
    Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
    Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
    Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients.
    Kawagoe Y; Hattori Y; Nakano A; Aoki C; Tanaka S; Ohta S; Iijima T; Tomizawa A; Jojima T; Kase H; Kasai K
    Endocr J; 2011; 58(3):171-5. PubMed ID: 21304215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of low-dose and standard-dose oral estrogen on forearm endothelial function in early postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1303-9. PubMed ID: 12629123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans.
    Yuan JN; Tsai MY; Hegland J; Hunninghake DB
    Atherosclerosis; 1991 Apr; 87(2-3):147-57. PubMed ID: 1854361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation.
    Duffy SJ; New G; Harper RW; Meredith IT
    Cardiovasc Res; 1999 Aug; 43(3):721-30. PubMed ID: 10690343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals.
    Leonhardt W; Kurktschiev T; Meissner D; Lattke P; Abletshauser C; Weidinger G; Jaross W; Hanefeld M
    Eur J Clin Pharmacol; 1997; 53(1):65-9. PubMed ID: 9349932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fluvastatin on parameters of bone remodeling.
    Bjarnason NH; Riis BJ; Christiansen C
    Osteoporos Int; 2001; 12(5):380-4. PubMed ID: 11444086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
    Farnier M; Dejager S
    Am J Cardiol; 2000 Jan; 85(1):53-7. PubMed ID: 11078237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.